Immediate Impact
4 from Science/Nature 50 standout
Citing Papers
Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis
2024 Standout
Non-steroidal anti-inflammatory drugs (NSAIDs): A current insight into its molecular mechanism eliciting organ toxicities
2023 Standout
Works of K Sidenius being referenced
Protocol for a multicentre randomised controlled trial to investigate the effect on asthma-related quality of life from breathing retraining in patients with incomplete asthma control attending specialist care in Denmark
2019
Efficacy, adverse events, and inter-drug comparison of mepolizumab and reslizumab anti-IL-5 treatments of severe asthma – a systematic review and meta-analysis
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| K Sidenius | 152 | 153 | 67 | 104 | 19 | 402 | |
| Allan Carmichael | 104 | 52 | 47 | 23 | 22 | 364 | |
| Maria Alexandra Rodrigues | 35 | 51 | 21 | 18 | 17 | 388 | |
| Maxwell Tran | 110 | 81 | 63 | 23 | 14 | 438 | |
| Scott T. Weiss | 227 | 89 | 86 | 28 | 11 | 423 | |
| Ruth Murray | 334 | 236 | 172 | 20 | 23 | 457 | |
| Daniel Hercz | 46 | 20 | 33 | 8 | 14 | 390 | |
| Orly Romano‐Zelekha | 58 | 58 | 67 | 5 | 24 | 432 | |
| Rishma Chooniedass | 89 | 116 | 29 | 5 | 21 | 360 | |
| Corinne Bois | 36 | 19 | 37 | 17 | 16 | 343 | |
| Audrey Dunn Galvin | 85 | 187 | 177 | 7 | 31 | 454 |
All Works
Login with ORCID to disown or claim papers
Loading papers...